Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial
Yifang Yuan(Beijing Tsinghua Chang Gung Hospital), Yangfeng Wu(Beijing Haidian Hospital), Ming‐Hui Zhao(China National Petroleum Corporation (China)), Wenyi Niu(Peking University), Darwin R. Labarthe(UK Health Forum), Sujuan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Paul Elliott(Ipsen (France)), Senke Hu(Xi'an Jiaotong University), Qianku Qiao, Pei Gao(Binzhou People's Hospital), Bruce Neal(UNSW Sydney), La’e Cao, Peifen Duan(Changzhi Medical College), Aoming Jin(National Clinical Research Center for Digestive Diseases), Hui Zhang(Jiangnan University), Hongxia Wang(Fudan University Shanghai Cancer Center), Jiayu Li(Changzhou University), Haijun Zhang(Johns Hopkins University), Huijuan Li(Cleveland Clinic), Ruijuan Zhang(Xi'an Jiaotong University), Hai Fang(King University), Xiangxian Feng(Changzhi Medical College), Junshi Chen, Gaoqiang Xie(Peking University), Lili Cheng, Jianhui Yuan(Central South University)
Cited by 104
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k